guest ::
| Home > Publications database > In Vivo Metabolic Imaging of [1-13C]Pyruvate-d3 Hyperpolarized By Reversible Exchange With Parahydrogen. > print |
| Home > Publications database > In Vivo Metabolic Imaging of [1-13C]Pyruvate-d3 Hyperpolarized By Reversible Exchange With Parahydrogen. > print |
| 001 | 277486 | ||
| 005 | 20240229162345.0 | ||
| 024 | 7 | _ | |a 10.1002/anie.202306654 |2 doi |
| 024 | 7 | _ | |a pmid:37439488 |2 pmid |
| 024 | 7 | _ | |a 1433-7851 |2 ISSN |
| 024 | 7 | _ | |a 0570-0833 |2 ISSN |
| 024 | 7 | _ | |a 1521-3773 |2 ISSN |
| 024 | 7 | _ | |a altmetric:151592793 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2023-01399 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 540 |
| 100 | 1 | _ | |a de Maissin, Henri |0 P:(DE-He78)0a5364096e6b6b262a5dd314d09e075b |b 0 |u dkfz |
| 245 | _ | _ | |a In Vivo Metabolic Imaging of [1-13C]Pyruvate-d3 Hyperpolarized By Reversible Exchange With Parahydrogen. |
| 260 | _ | _ | |a Weinheim |c 2023 |b Wiley-VCH |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1693478811_10457 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2023 Sep 4;62(36):e202306654 |
| 520 | _ | _ | |a Metabolic magnetic resonance imaging (MRI) using hyperpolarized (HP) pyruvate is becoming a non-invasive technique for diagnosing, staging, and monitoring response to treatment in cancer and other diseases. The clinically established method for producing HP pyruvate, dissolution dynamic nuclear polarization, however, is rather complex and slow. Signal Amplification By Reversible Exchange (SABRE) is an ultra-fast and low-cost method based on fast chemical exchange. Here, for the first time, we demonstrate not only in vivo utility, but also metabolic MRI with SABRE. We present a novel routine to produce aqueous HP [1-13C]pyruvate-d3 for injection in 6 minutes. The injected solution was sterile, non-toxic, pH neutral and contained ≈30 mM [1-13C]pyruvate-d3 polarized to ≈11% (residual 250 mM methanol and 20 µM catalyst). It was obtained by rapid solvent evaporation and metal filtering, which we detail in this manuscript. This achievement makes HP pyruvate MRI available to a wide biomedical community for fast metabolic imaging of living organisms. |
| 536 | _ | _ | |a 899 - ohne Topic (POF4-899) |0 G:(DE-HGF)POF4-899 |c POF4-899 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a SABRE |2 Other |
| 650 | _ | 7 | |a hyperpolarization |2 Other |
| 650 | _ | 7 | |a metabolic imaging |2 Other |
| 650 | _ | 7 | |a parahydrogen |2 Other |
| 650 | _ | 7 | |a pyruvate |2 Other |
| 700 | 1 | _ | |a Groß, Philipp R |b 1 |
| 700 | 1 | _ | |a Mohiuddin, Obaid |b 2 |
| 700 | 1 | _ | |a Weigt, Moritz |b 3 |
| 700 | 1 | _ | |a Nagel, Luca |b 4 |
| 700 | 1 | _ | |a Herzog, Marvin |b 5 |
| 700 | 1 | _ | |a Wang, Zirun |b 6 |
| 700 | 1 | _ | |a Willing, Robert |0 P:(DE-He78)0360793e318e7dbe59001a00beac85f5 |b 7 |u dkfz |
| 700 | 1 | _ | |a Reichardt, Wilfried |b 8 |
| 700 | 1 | _ | |a Pichotka, Martin |b 9 |
| 700 | 1 | _ | |a Heß, Lisa |b 10 |
| 700 | 1 | _ | |a Reinheckel, Thomas |0 P:(DE-HGF)0 |b 11 |
| 700 | 1 | _ | |a Jessen, Henning J |b 12 |
| 700 | 1 | _ | |a Zeiser, Robert |0 P:(DE-HGF)0 |b 13 |
| 700 | 1 | _ | |a Bock, Michael |b 14 |
| 700 | 1 | _ | |a von Elverfeldt, Dominik |b 15 |
| 700 | 1 | _ | |a Zaitsev, Maxim |b 16 |
| 700 | 1 | _ | |a Korchak, Sergey |b 17 |
| 700 | 1 | _ | |a Glöggler, Stefan |b 18 |
| 700 | 1 | _ | |a Hövener, Jan-Bernd |b 19 |
| 700 | 1 | _ | |a Chekmenev, Eduard Y |b 20 |
| 700 | 1 | _ | |a Schilling, Franz |0 P:(DE-HGF)0 |b 21 |
| 700 | 1 | _ | |a Knecht, Stephan |b 22 |
| 700 | 1 | _ | |a Schmidt, Andreas |0 P:(DE-He78)17e270765cb79a4a3b19014bbb1095bb |b 23 |u dkfz |
| 773 | _ | _ | |a 10.1002/anie.202306654 |g p. e202306654 |0 PERI:(DE-600)2011836-3 |n 36 |p e202306654 |t Angewandte Chemie / International edition |v 62 |y 2023 |x 1433-7851 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:277486 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)0a5364096e6b6b262a5dd314d09e075b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)0360793e318e7dbe59001a00beac85f5 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 21 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 23 |6 P:(DE-He78)17e270765cb79a4a3b19014bbb1095bb |
| 913 | 1 | _ | |a DE-HGF |b Programmungebundene Forschung |l ohne Programm |1 G:(DE-HGF)POF4-890 |0 G:(DE-HGF)POF4-899 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-800 |4 G:(DE-HGF)POF |v ohne Topic |x 0 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2022-11-11 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1210 |2 StatID |b Index Chemicus |d 2022-11-11 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1200 |2 StatID |b Chemical Reactions |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-11 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-08-19 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ANGEW CHEM INT EDIT : 2022 |d 2023-08-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-08-19 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-08-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-08-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-08-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-08-19 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |d 2023-08-19 |
| 915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b ANGEW CHEM INT EDIT : 2022 |d 2023-08-19 |
| 920 | 1 | _ | |0 I:(DE-He78)FR01-20160331 |k FR01 |l DKTK Koordinierungsstelle Freiburg |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)MU01-20160331 |k MU01 |l DKTK Koordinierungsstelle München |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)FR01-20160331 |
| 980 | _ | _ | |a I:(DE-He78)MU01-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|